Bisaro Paul bought MYGN
June 4, 2026 · Form 4 insider transaction
Bisaro Paul bought 59,701 shares of Myriad Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
59,701
Price
$0.00
Total value
N/A
InsiderBisaro Paul
Role—
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 4, 2026
Filing dateJune 5, 2026
Shares owned after157,142
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.